Edwards Lifesciences Corp (EW)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 9,998,400 | 6,650,000 | 5,806,700 | 5,835,900 | 4,574,300 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $9,998,400K)
= 0.00
The debt-to-capital ratio for Edwards Lifesciences Corp has remained consistently at 0.00% from December 31, 2020, to December 31, 2024. This indicates that the company has not used debt as a significant source of capital relative to its total capital structure during this period. A debt-to-capital ratio of 0.00% suggests that the company's capital is primarily derived from equity, reflecting a lower financial risk as there is no debt obligation to service. This stable ratio may imply a conservative financial strategy focused on maintaining a healthy balance sheet position and potentially avoiding the risks associated with high debt levels.
Peer comparison
Dec 31, 2024